11/01/2019 12:00:00

Peeks Social Closes Second Tranche of Convertible Debenture Financing

TORONTO, Jan. 11, 2019 (GLOBE NEWSWIRE) -- Peeks Social Ltd. (TSXV: PEEK; OTCQB: PKSLF) (“Peeks Social” or the “Company”) is pleased to announce that it has closed the second tranche (the “Second Tranche”) of its non-brokered private placement of senior secured convertible debentures (“Debentures”) announced in its December 27, 2018 news release (the “Offering”).

The Second Tranche was comprised of Debentures in the principal amount of $52,500. Debentures issued under the Second Tranche will have a term of two years and will bear interest at a rate of 8% per annum, provided that the interest rate will increase to 12% per annum upon the occurrence of certain events of default. Further, the repayment of the principal amount of the Debentures and any accrued but unpaid interest thereon will be secured by a general security agreement over all of the Company’s assets. The Debentures will be convertible, in whole or in part, at the option of the holder, into common shares of the Company (“Common Shares”), at a conversion price of $0.10 per Common Share. Each Debenture will also include one Common Share purchase warrant (a “Warrant”). Each Warrant will entitle the holder thereof to acquire one additional Common Share at a price of $0.15 per Common Share, provided that, if the Company subsequently issues Common Shares at a price of less than $0.10 per Common Share (a “Down Round”), it will, subject to the approval of the Exchange, amend the exercise price of the Warrants to match the issuance price of the Common Shares issued in such Down Round.

In connection with the Second Tranche, the Company has paid a cash finder’s fee of $3,250 to First Republic Capital Corporation (“FirstRepublic”), representing 6.5% of the principal amount of the Debentures issued in the Second Tranche, and has issued to First Republic 26,250 Warrants, which are exercisable into 5% of the Common Shares underlying the Debentures issued pursuant to the Second Tranche. All securities issued pursuant to the Offering will be subject to a hold period of four months plus one day following closing.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has reviewed or accepts responsibility for the adequacy or accuracy of this Release.

For further information, please contact:

Peeks Social Ltd.

Mark ItwaruDavid Vinokurov
Chairman & Chief Executive OfficerDirector Investor Relations
416-639-5339416-716-9281

mark@peeks.com

davidv@peeks.com

Forward-Looking Statements

Certain statements contained in this press release contain forward-looking statements within the meaning of Canadian securities laws. Words such as “may,” “would,” “could,” “should,” “potential,” “will,” “seek,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “expect” and similar expressions as they relate to the Company, including closing of the Offering, are intended to identify forward-looking information. All statements other than statements of historical fact may be forward-looking information. Such statements reflect the Company’s current views and intentions with respect to future events, based on information available to the Company, and are subject to certain risks, uncertainties and assumptions. Material factors or assumptions were applied in providing forward-looking information, including: receipt of the approval of the TSX Venture Exchange and the directors of the Company for the transactions; successfully negotiating definitive terms with the lender for the Offering; and closing conditions being met. While forward-looking statements are based on data, assumptions and analyses that the Company believes are reasonable under the circumstances, whether actual results, performance or developments will meet the Company’s expectations and  predictions depends on a number of risks and uncertainties that could cause the actual results, performance and financial condition of the Company to differ materially from its expectations. Should any factor affect the Company in an unexpected manner, or should assumptions underlying the forward - looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, the Company does not assume responsibility for the accuracy or completeness of such forward-looking information. The forward-looking information included in this press release is made as of the date of this press release, and the Company undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law.

The securities referred to in this news release have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent U.S. registration or an applicable exemption from the U.S. registration requirements. This news release does not constitute an offer for sale of securities, nor a solicitation for offers to buy any securities. Any public offering of securities in the United States must be made by means of a prospectus containing detailed information about the company and management, as well as financial statements.

logo_trans.png

Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
20 Jun
 
I øjeblikket sidder "vinderne" ved folketingsvalget og forhandler regeringsgrundlag. De er enige om ..
45
20 Jun
 
Måske jeg er den eneste, men savner Alpehue og hans gode indlæg... er han her under et andet alias? ..
23
23 Jun
 
Kære Nets-formand, du er i Danmark, ikke USA Vi er et samfund, hvor få har for meget og færre for li..
21
21 Jun
VELO
Mangel på to tacrolimus - konvertere pat. til Envarsus   I USA konvertere de patienter til Envarsus ..
20
21 Jun
 
@ckt - synes egentlig det havde vaeret bedre, du ikke havde skrevet noget overhovedet..
20
19 Jun
OMXC25
  De vil aldrig få penge nok. Jeg vil tro, at der aldrig er tilført de offentlige kasser flere penge..
20
20 Jun
CHEMM
ChemoMetec opjusterer forventningerne til omsætningen og driftsresultatet som følger af højere forve..
19
25 Jun
VELO
https://m.medwatch.dk/article/11464164
18
21 Jun
VELO
Ser ud til at man omkring 1 juli starter et nyt forsøg op med Envarsus hvor man tilsyneladende forve..
17
25 Jun
VELO
Jeg har lavet denne beregning, min forventning til Q1 ramte kun 9.000 USD ved siden af. Siden har je..
16

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Shareholder Alert: Securities Class Action Lawsuit Filed Against Eros International PLC – EROS – Kehoe Law Firm, P.C. Investigating Claims on Behalf of Eros Investors
2
UPDATE – PREMIA and AmoyDx Announce Strategic Partnership to Establish Asia Cancer Clinical Genomic Network
3
IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Anheuser-Busch InBev SA/NV and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
4
AOS INVESTOR DEADLINE REMINDER: Hagens Berman Reminds A.O. Smith (AOS) Investors of Lead Plaintiff Deadline, Encourages Investors Who Suffered $50,000+ Losses to Contact the Firm
5
Annual Financial Report and Notice of Annual General Meeting

Latest news


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
25 June 2019 23:51:59
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190527.1 - EUROWEB2 - 2019-06-26 00:51:59 - 2019-06-25 23:51:59 - 1000 - Website: OKAY